Brochure: Integrated bioprocessing
Posted: 1 April 2021 | Merck | No comments yet
The journey from large molecule to approved biotherapeutic is long, costly, complex, and fraught with risk – yet rewards for success are substantial.
Knowing what to expect and who and where to go for guidance can provide confidence, you’re on the right track and accelerate the journey. From bench to full-scale production, we offer a full range of raw materials, tools, services, and technologies, from off-the-shelf to customizable, to accelerate development, optimization and scale-up of your process. Our in-house experts have decades of bioprocessing experience and will collaborate with you to tackle any development and processing challenge, as well as provide guidance on regulatory expectations and testing requirements to meet your compliance needs.
Related content from this organisation
- Microbial air sampler market to value $545mn by 2028
- Has the threat of waiving COVID-19 vaccine intellectual property rights had its desired effect?
- 2021 a pivotal year for personalised neoantigens, says GlobalData
- Strengthening the pharma industry’s cyber security defence
- Collaboration to develop neurostimulator for inflammatory disease treatment
Related topics
Biologics, Biopharmaceuticals, Bioprocessing, Biosimilars, Chromatography, Excipients, Formulation, Gene therapy, Good Manufacturing Practice (GMP), Manufacturing, Outsourcing
